Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.


Journal

Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268

Informations de publication

Date de publication:
Feb 2023
Historique:
pubmed: 7 8 2022
medline: 3 2 2023
entrez: 6 8 2022
Statut: ppublish

Résumé

The Ukrainian Lymphoma Registry (ULR) was established in 2019 with the aim of monitoring the quality of diagnosis, staging, and treatment of lymphoma in Ukraine. Between September 2019 and October 2021, 546 patients with newly diagnosed lymphoma were prospectively registered. All cases were diagnosed according to the 2016 updated WHO lymphoma classification. The male-to-female ratio (M/F) for the whole population was 0.7, with a median age of 46 years (range 18-95). The adoption of the 2016 WHO classification resulted in the identification of 36 different lymphoma subtypes, with 132 cases (24.2%) classified differently compared to the 2008 WHO classification. Only 12 cases (2.8%) were true new entities, including seven cases of high-grade B-cell lymphoma NOS, three of anaplastic large B-cell lymphoma, ALK-negative, 1 case of HHV8+ DLBCL NOS, and 1 of high-grade B-cell lymphoma with C-MYC and BCL2/BCL6 rearrangement. Moreover, 55 (61.1%) entities, including 37 defined by WHO 2008 and 18 defined by WHO 2016, were not represented at all. The analysis of cases registered in the ULR provides a comprehensive breakdown of the subtypes, stage distribution, and treatment of malignant lymphomas (ML) in Ukraine, supporting the usefulness of prospective data collection and timely reporting. We believe that this study is the first step toward a better understanding of the real-life outcomes of patients with ML.

Identifiants

pubmed: 35932211
doi: 10.1002/hon.3061
pmc: PMC10087250
doi:

Substances chimiques

Proto-Oncogene Proteins c-bcl-2 0
Proto-Oncogene Proteins c-bcl-6 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

196-200

Subventions

Organisme : Associazione Angela Serra per la Ricerca sul Cancro

Informations de copyright

© 2022 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.

Références

Jpn J Clin Oncol. 2020 Jan 24;50(1):96-97
pubmed: 31868886
Br J Haematol. 2020 Jun;189(6):1083-1092
pubmed: 32065396
Hematol Oncol. 2007 Dec;25(4):189-97
pubmed: 17654762
Mod Pathol. 2016 Oct;29(10):1173-82
pubmed: 27312067
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Eur J Cancer. 2007 Jan;43(2):391-401
pubmed: 17134891
Leuk Lymphoma. 2003 May;44(5):801-6
pubmed: 12802917

Auteurs

Iryna Kriachok (I)

Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.

Yana Stepanishyna (Y)

Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.

Tetiana Skrypets (T)

Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Nazar Shokun (N)

Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.

Arina Martynchyk (A)

Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.

Iryna Tytorenko (I)

Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.

Olena Aleksik (O)

Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.

Mykhailo Krotevych (M)

Pathology Department, National Cancer Institute, Kyiv, Ukraine.

Martina Manni (M)

Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Massimo Federico (M)

Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH